Oncology: RAS, ADCs, bispecifics & the IO-backbone fight 59 links · hubs RVMD, MRK, BMY, SMMT, GMAB, LLY
Rare disease, cardio-metabolic & genetic medicines: head-to-head races and FDA gates 57 links · hubs ALNY, NVS, AMGN, BMY, FDA, REGN
GLP-1 / Obesity Value Chain 47 links · hubs LLY, NVO, CMS
Next-gen immunology: degraders, bispecifics, celiac & in-vivo CAR-T 29 links · hubs SNY, ABBV, REGN, LLY, ARGX, RHHBY
HS & TL1A Immunology Race 24 links · hubs ABBV, MRK, MLTX
Medtech: share shifts in robotics, cardio, ortho & ophthalmology 21 links · hubs MDT, ISRG, BSX, EW, SYK, CMS
Biopharma BD: patent-cliff M&A, royalties & biosimilars 17 links · hubs LLY, MRK, ABBV, GILD, VRTX
Diagnostics, lab reimbursement & imaging agents 15 links · hubs CMS, GH, LH, DGX, RHHBY
Drug distribution, specialty pharmacy & oncology practices 12 links · hubs MCK, CAH, MDLN, CVS
Managed care, dialysis & digital health benefits 10 links · hubs UNH, HUM, ELV, DVA, CMS
Life-science tools, CDMOs & clinical services 8 links · hubs TMO, DHR, IQV, Catalent
Drug pricing policy: IRA negotiation, MFN deals & FDA inspections 8 links · hubs CMS, FDA, GILD, AZN
AI drug discovery & biological data 6 links · hubs LLY, TEM, TWST, Anthropic
Wet AMD: long-acting TKIs & gene therapy 5 links · hubs OCUL, EYPT, FDMT, RGNX
Pneumococcal & respiratory vaccines 4 links · hubs PCVX, PFE, MRK, NVAX